Preparation and characterization of vemurafenib microemulsion

Human melanoma is the most common and malignant type of skin cancer. Vemurafenib has been used for the treatment of malignant or metastatic melanoma. Oral vemurafenib has serious adverse drug reactions including QTc sigment prolongation of heart ECG that may result in discontinuation of treatment...

Full description

Bibliographic Details
Main Authors: Mohammed Jassim Neamah, Entidhar J. Al-Akkam
Format: Article
Language:English
Published: College of Pharmacy University of Baghdad 2023-11-01
Series:Iraqi Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2607
_version_ 1797635806256431104
author Mohammed Jassim Neamah
Entidhar J. Al-Akkam
author_facet Mohammed Jassim Neamah
Entidhar J. Al-Akkam
author_sort Mohammed Jassim Neamah
collection DOAJ
description Human melanoma is the most common and malignant type of skin cancer. Vemurafenib has been used for the treatment of malignant or metastatic melanoma. Oral vemurafenib has serious adverse drug reactions including QTc sigment prolongation of heart ECG that may result in discontinuation of treatment. The aim of study was to prepare o/w vemurafenib microemulsion to be used for topical administration. Saturated solubility of vemurafenib were performed in different oils, surfactants and co-surfactants. Peppermint oil, Tween 20 and PEG 400 were chosen to be the oil phase, surfactant and co-surfactant repectively. Since, vemurafenib had the highest solubility in these materials. Six fromulas (F1- F6) of vemurafenib microemulsion were prepared by simple titration method and characterized for their particle size, polydipersity (PDI), zeta potential, microemulsion morphology, dilution test, conductivity, thermodynamic stability and drug release. Formula F3 was chosen since it exhibits the lowest particle size (11.83 nm ± 0.55 nm), zeta potential -2.57 mV, passed the thermodynamic stability tests and had significantly higher (P < 0.05) release percent for vemurafenib (91% within 24 h). As a conclusion, microemulsion is considered as a poweful and promising drug delivery system for topical administation
first_indexed 2024-03-11T12:26:36Z
format Article
id doaj.art-4d648a2a3a8246d3a8000f6d36735f2d
institution Directory Open Access Journal
issn 1683-3597
2521-3512
language English
last_indexed 2024-03-11T12:26:36Z
publishDate 2023-11-01
publisher College of Pharmacy University of Baghdad
record_format Article
series Iraqi Journal of Pharmaceutical Sciences
spelling doaj.art-4d648a2a3a8246d3a8000f6d36735f2d2023-11-06T08:57:52ZengCollege of Pharmacy University of BaghdadIraqi Journal of Pharmaceutical Sciences1683-35972521-35122023-11-0132Suppl.10.31351/vol32issSuppl.pp316-325Preparation and characterization of vemurafenib microemulsionMohammed Jassim Neamah0Entidhar J. Al-Akkam1Departure of Pharmaceutics, College of Pharmacy, University of Baghdad, Iraq.Departure of Pharmaceutics, College of Pharmacy, University of Baghdad, Iraq. Human melanoma is the most common and malignant type of skin cancer. Vemurafenib has been used for the treatment of malignant or metastatic melanoma. Oral vemurafenib has serious adverse drug reactions including QTc sigment prolongation of heart ECG that may result in discontinuation of treatment. The aim of study was to prepare o/w vemurafenib microemulsion to be used for topical administration. Saturated solubility of vemurafenib were performed in different oils, surfactants and co-surfactants. Peppermint oil, Tween 20 and PEG 400 were chosen to be the oil phase, surfactant and co-surfactant repectively. Since, vemurafenib had the highest solubility in these materials. Six fromulas (F1- F6) of vemurafenib microemulsion were prepared by simple titration method and characterized for their particle size, polydipersity (PDI), zeta potential, microemulsion morphology, dilution test, conductivity, thermodynamic stability and drug release. Formula F3 was chosen since it exhibits the lowest particle size (11.83 nm ± 0.55 nm), zeta potential -2.57 mV, passed the thermodynamic stability tests and had significantly higher (P < 0.05) release percent for vemurafenib (91% within 24 h). As a conclusion, microemulsion is considered as a poweful and promising drug delivery system for topical administation https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2607spseudoternary phase diagram
spellingShingle Mohammed Jassim Neamah
Entidhar J. Al-Akkam
Preparation and characterization of vemurafenib microemulsion
Iraqi Journal of Pharmaceutical Sciences
spseudoternary phase diagram
title Preparation and characterization of vemurafenib microemulsion
title_full Preparation and characterization of vemurafenib microemulsion
title_fullStr Preparation and characterization of vemurafenib microemulsion
title_full_unstemmed Preparation and characterization of vemurafenib microemulsion
title_short Preparation and characterization of vemurafenib microemulsion
title_sort preparation and characterization of vemurafenib microemulsion
topic spseudoternary phase diagram
url https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2607
work_keys_str_mv AT mohammedjassimneamah preparationandcharacterizationofvemurafenibmicroemulsion
AT entidharjalakkam preparationandcharacterizationofvemurafenibmicroemulsion